ICD-10-CM 2027 diagnosis code
D48.116Desmoid tumor of lower extremity and pelvic girdle
D48.116 is a valid, billable ICD-10-CM code for desmoid tumor of lower extremity and pelvic girdle. It can be reported on claims for dates of service from October 1, 2026 – September 30, 2027.
Code last changed in FY2024 (effective October 1, 2023). Source: official FY2027 ICD-10-CM release from CDC/NCHS and CMS. Page updated September 29, 2026. About our data
About D48.116
D48.116 is the ICD-10-CM diagnosis code for Desmoid tumor of lower extremity and pelvic girdle. It belongs to category D48 (neoplasm of uncertain behavior of other and unspecified sites), block D37-D48 (neoplasms of uncertain behavior, polycythemia vera and myelodysplastic syndromes) and chapter 2 (neoplasms). It is billable, so it can be reported on its own for dates of service from October 1, 2026 through September 30, 2027.
Within D48.11 (Desmoid tumor), D48.116 is specifically for Desmoid tumor of lower extremity and pelvic girdle. Related codes cover of head and neck (D48.110), of chest wall (D48.111), intrathoracic (D48.112), of abdominal wall (D48.113), intraabdominal (D48.114), of upper extremity and shoulder girdle (D48.115), of back (D48.117), of other site (D48.118) and 1 more.
It is not a CC or MCC, so as a secondary diagnosis it doesn't change the MS-DRG severity level.
In MS-DRG v44.0, it is part of the grouping logic for DRG 564 (Other Musculoskeletal System and Connective Tissue Diagnoses with MCC, relative weight 1.4908), DRG 565 (Other Musculoskeletal System and Connective Tissue Diagnoses with CC, relative weight 0.9783) and DRG 566 (Other Musculoskeletal System and Connective Tissue Diagnoses without CC/MCC, relative weight 0.7378), in MDC 08 (Diseases and Disorders of the Musculoskeletal System and Connective Tissue), as a principal or secondary diagnosis. The DRG a claim lands in depends on the principal diagnosis, procedures and any CC/MCC secondary diagnoses.
It was added in FY2024, effective October 1, 2023.
Coding notes
- Desmoid tumor of buttock
Notes that apply from higher levels
Instructions written at a parent level also apply to D48.116.
› From D48 Neoplasm of uncertain behavior of other and unspecified sites
- neurofibromatosis (nonmalignant) (Q85.0-)
Broader instructions also apply from D37-D48 Neoplasms of uncertain behavior, polycythemia vera and myelodysplastic syndromes and Chapter 2: Neoplasms.
Alphabetic index entries
3 entriesTerms in the official ICD-10-CM index that lead to D48.116.
MS-DRG v44.0 grouping
All DRGs →Inpatient MS-DRGs this diagnosis can group to, as the principal or a secondary diagnosis, depending on the rest of the claim.
MDC 08 · Diseases and Disorders of the Musculoskeletal System and Connective Tissue
Code history
- 2016
- 2017
- 2018
- 2019
- 2020
- 2021
- 2022
- 2023
- 2024
- 2025
- 2026
- 2027
- FY2024 (effective 10/1/2023): Added
- No changes since FY2024.
Common questions about D48.116
Is D48.116 billable?
- Yes. D48.116 is a billable/specific ICD-10-CM code valid for FY2027 (October 1, 2026 – September 30, 2027).
Can D48.116 be used as a principal diagnosis?
- Yes. The Medicare Code Editor doesn't restrict D48.116 as a principal diagnosis.
Is D48.116 a CC or MCC?
- No. D48.116 is neither a CC nor an MCC under MS-DRG v44.0.
What DRG does D48.116 group to?
- D48.116 is used in the MS-DRG v44.0 logic for MS-DRG 564 (Other Musculoskeletal System and Connective Tissue Diagnoses with MCC), MS-DRG 565 (Other Musculoskeletal System and Connective Tissue Diagnoses with CC) and MS-DRG 566 (Other Musculoskeletal System and Connective Tissue Diagnoses without CC/MCC). Which one applies depends on whether it is the principal diagnosis and on the rest of the claim.